Audit 296974

FY End
2022-09-30
Total Expended
$465.82M
Findings
4
Programs
80
Organization: Beth Israel Lahey Health, Inc. (MA)
Year: 2022 Accepted: 2024-03-24
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
383958 2022-001 Significant Deficiency - L
383959 2022-002 Material Weakness - L
960400 2022-001 Significant Deficiency - L
960401 2022-002 Material Weakness - L

Programs

ALN Program Spent Major Findings
93.498 Cares Act $249.51M Yes 1
97.036 United States Department of Homeland Security $14.25M Yes 1
93.273 National Institutes of Health $1.88M - 0
16.320 Department of Defense $960,555 - 0
93.360 National Institutes of Health $836,748 - 0
93.461 Health Resources and Services Administration $689,703 - 0
93.351 National Institutes of Health $604,221 - 0
47.041 National Science Foundation $569,853 - 0
93.839 National Institutes of Health $391,320 - 0
93.350 National Institutes of Health $371,974 - 0
93.839 National Institutes of Health $370,915 - 0
93.958 Substance Abuse and Mental Health Services Administration: $295,032 - 0
93.226 Agency for Health Care Policy and Research $217,603 - 0
93.918 Health Resources and Services Administration $212,962 - 0
93.351 National Institutes of Health $200,355 - 0
93.788 Substance Abuse and Mental Health Services Administration: $185,702 - 0
93.859 National Institutes of Health $183,507 - 0
93.914 Health Resources and Services Administration $133,190 - 0
16.320 Department of Justice $123,907 - 0
93.847 National Institutes of Health $110,311 - 0
93.172 National Institutes of Health $101,398 - 0
93.145 Health Resources and Services Administration $100,933 - 0
93.RD Agency for Health Care Policy and Research $97,554 - 0
93.213 National Institutes of Health $94,153 - 0
21.027 Substance Abuse and Mental Health Services Administration: $79,663 - 0
93.067 Centers for Disease Control $66,482 - 0
93.866 National Institutes of Health $64,236 - 0
93.838 National Institutes of Health $62,256 - 0
93.286 National Institutes of Health $54,482 - 0
93.355 National Institutes of Health $53,299 - 0
93.859 National Institutes of Health $51,227 - 0
93.394 National Institutes of Health $51,167 - 0
93.847 National Institutes of Health $43,565 - 0
93.853 National Institutes of Health $43,537 - 0
93.361 National Institutes of Health $40,703 - 0
83.838 National Institutes of Health $40,295 - 0
43.001 National Aeronautic & Space Administration $36,363 - 0
93.396 National Institutes of Health $33,024 - 0
93.310 National Institutes of Health $32,946 - 0
93.853 National Institutes of Health $27,520 - 0
93.867 National Institutes of Health $25,610 - 0
93.310 National Institutes of Health $25,396 - 0
93.855 National Institutes of Health $24,701 - 0
93.113 National Institutes of Health $20,334 - 0
93.865 National Institutes of Health $17,132 - 0
93.959 National Institutes of Health $15,667 - 0
93.103 Food and Drug Administration $15,328 - 0
93.279 National Institutes of Health $14,035 - 0
12.420 U.s. Army Medical Command $11,421 - 0
93.395 National Institutes of Health $11,095 - 0
94.846 National Institutes of Health $11,008 - 0
93.361 National Institutes of Health $5,897 - 0
93.242 National Institutes of Health $4,704 - 0
93.279 National Institutes of Health $3,930 - 0
93.838 National Institutes of Health $3,306 - 0
93.226 Agency for Healthcare Research and Quality $2,913 - 0
93.243 National Institutes of Health $2,636 - 0
93.360 National Institutes of Health $2,421 - 0
93.242 National Institutes of Health $1,968 - 0
93.959 Substance Abuse and Mental Health Services Administration: $1,877 - 0
93.837 National Institutes of Health $1,747 - 0
93.866 National Institutes of Health $1,379 - 0
93.846 National Institutes of Health $1,274 - 0
93.865 National Institutes of Health $1,042 - 0
93.846 National Institutes of Health $382 - 0
93.867 National Institutes of Health $210 - 0
93.350 National Institutes of Health $195 - 0
93.273 National Institutes of Health $174 - 0
93.286 National Institutes of Health $164 - 0
12.910 Defense Advanced Research Projects Agency $31 - 0
93.307 National Institutes of Health $21 - 0
98.001 National Institutes of Health $18 - 0
93.855 National Institutes of Health $-724 - 0
93.121 National Institutes of Health $-1,273 - 0
93.307 National Institutes of Health $-1,436 - 0
93.RD Centers for Disease Control $-1,737 - 0
93.396 National Institutes of Health $-2,640 - 0
16.575 Department of Justice $-4,091 - 0
93.837 National Institutes of Health $-4,301 - 0
93.879 National Institutes of Health $-10,890 - 0

Contacts

Name Title Type
C1CPANL3EWK4 Jarod Kohr Auditee
6176674136 Jayme M. Silva Auditor
No contacts on file

Notes to SEFA

Accounting Policies: (1) Definition of Reporting EntityThe schedule of expenditures of federal awards (the Schedule) presents the activity of all federal awards of Beth Israel Lahey Health, Inc. and Affiliates (BILH). All federal awards received directly from federal agencies, as well as federal awards passed through other agencies, are included on the Schedule.(2) Basis of PresentationThe accompanying Schedule is presented using the cash basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulation Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Negative amounts shown on the Schedule representadjustments or credits made in the normal course of business to amounts reported as expenditures in prior years.(3) Indirect CostsIndirect costs are charged to federal grants and contracts at a federally approved predetermined rate. The predetermined rate for the period October 1, 2012 until amended is between 73% and 75%. Indirect costs are included in the reported federal expenditures.BILH has not elected to utilize the 10% deminimus indirect cost rate in Part 200.514 of the UniformGuidance.51 De Minimis Rate Used: N Rate Explanation: The Auditee did not use the de minimis cost rate.

Finding Details

(3) Findings and Questioned Costs Relating to Federal Awards Finding 2022-001 Federal Agency: United States Department of Health and Human Services Program Name: Provider Relief Fund (PRF) Assistance Listing Number: 93.498 Criteria: PRF recipients that received one or more payments exceeding $10,000 in the aggregate during a Payment Received Period are required to report on several required data elements as part of the post-payment reporting process. Reporting must be completed and submitted to the Health Resources and Service Administration (HRSA) the reporting dates specified by HRSA. Additionally, Title 45 U.S. Code of Federal Regulations Part 75 (45 CFR 75), Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, section 03(a) states the non-Federal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Condition: During our audit procedures for Beth Israel Lahey Health’s PRF Reporting Periods 2 and 3, we identified an error in the amount reported on the Lost Revenue in Excess of Total Distributions line item for the period of January 2020 to June 2021 for Beth Israel Deaconess Medical Center (BIDMC). Management incorrectly utilized the same quarterly budget amount for Quarter 3 and Quarter 4 within their internal lost revenue calculations spreadsheet. The error resulted in $160,417,776 being reported as Lost Revenue in Excess of Total Distributions within the report instead of $167,748,797, or understating the lost revenue amount by $7,331,021. We deemed this to be a significant deficiency in internal controls. Cause: The condition found results from the existing internal control review over the accuracy of the underlying data used to prepare the report not being performed at a precision level that detected the error duplicating the budget amounts from Quarter 3 to Quarter 4. Possible Asserted Effect: Failure to ensure accuracy of amounts reported as “Lost Revenues in Excess of Total Distributions” may result in HRSA relying on incomplete or inaccurate information associated to the BILH’s utilization of PRF funds. Questioned Costs: None. Statistical Sampling: The sample was not intended to be, and was not, a statistically valid sample. Identification of Whether the Audit Finding was a Repeat Finding: This is not a repeat finding. Recommendation: We recommend BILH enhance its internal controls over PRF reporting to ensure each of the data elements reported to HRSA are accurate and result in amounts consistent with its underlying records. Views of Responsible Officials: Management will enhance its internal controls over PRF reporting by requiring co-sign off by the VP of System Services Accounting and the VP of Revenue/Reimbursement.
Finding 2022-02 – Reporting Program: COVID-19 Disaster Grants – Public Assistance (Presidentially Declared Disasters) Federal Agency: U.S. Department of Homeland Security Assistance Listing Number: 97.036 Criteria: Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) Subpart F – Audit Requirements §200.510 requires the auditee to prepare a schedule of expenditures of Federal awards for the period covered by the auditee’s financial statements which must include the total Federal awards expended as determined in accordance with §200.502. The Uniform Guidance requires the auditor to determine whether the auditee’s schedule of expenditures of federal awards is fairly stated, in all material respects, in relation to the audited entity’s financial statements as a whole. In addition, the Uniform Guidance places the responsibility for identifying major programs on the auditor and the schedule of expenditures of federal awards serves as the primary basis for the auditor’s major program determination. Therefore, appropriate major program determination by the auditor is dependent on the accuracy and completeness of the information in the schedule of expenditures of federal awards. Condition: In preparation of the schedule of expenditures for federal awards (SEFA) management did not record the COVID-19 Disaster Grants – Public Assistance (Presidentially Declared Disasters) expenditures on the SEFA which resulted in the SEFA being understated by $14,249,269. We deemed this to be a material weakness in internal controls. Cause: BILH did not have an adequately designed internal control to identify the error in federal awards expended as such, the amount of the errors could have been greater and not detected by BILH’s control environment. Possible Asserted Effect: Potential misstatement to the schedule of expenditures of federal awards. Questioned Costs: None noted Statistical Sampling: The sample was not intended to be, and was not, a statistically valid sample. Identification of Whether the Audit Finding was a Repeat Finding: This is not a repeat finding. Recommendation: We recommend that BILH implement a more thorough and detailed process for preparing and reviewing the SEFA to identify adjustments that could result in a misstatement of the SEFA. This should include a formalized and detailed review of the SEFA and a reconciliation to the general ledger and financial statements by someone other than the preparer. Views of Responsible Officials: Management will enhance its review process by requiring a formal second sign-off of the SEFA with supporting documents.
(3) Findings and Questioned Costs Relating to Federal Awards Finding 2022-001 Federal Agency: United States Department of Health and Human Services Program Name: Provider Relief Fund (PRF) Assistance Listing Number: 93.498 Criteria: PRF recipients that received one or more payments exceeding $10,000 in the aggregate during a Payment Received Period are required to report on several required data elements as part of the post-payment reporting process. Reporting must be completed and submitted to the Health Resources and Service Administration (HRSA) the reporting dates specified by HRSA. Additionally, Title 45 U.S. Code of Federal Regulations Part 75 (45 CFR 75), Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, section 03(a) states the non-Federal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Condition: During our audit procedures for Beth Israel Lahey Health’s PRF Reporting Periods 2 and 3, we identified an error in the amount reported on the Lost Revenue in Excess of Total Distributions line item for the period of January 2020 to June 2021 for Beth Israel Deaconess Medical Center (BIDMC). Management incorrectly utilized the same quarterly budget amount for Quarter 3 and Quarter 4 within their internal lost revenue calculations spreadsheet. The error resulted in $160,417,776 being reported as Lost Revenue in Excess of Total Distributions within the report instead of $167,748,797, or understating the lost revenue amount by $7,331,021. We deemed this to be a significant deficiency in internal controls. Cause: The condition found results from the existing internal control review over the accuracy of the underlying data used to prepare the report not being performed at a precision level that detected the error duplicating the budget amounts from Quarter 3 to Quarter 4. Possible Asserted Effect: Failure to ensure accuracy of amounts reported as “Lost Revenues in Excess of Total Distributions” may result in HRSA relying on incomplete or inaccurate information associated to the BILH’s utilization of PRF funds. Questioned Costs: None. Statistical Sampling: The sample was not intended to be, and was not, a statistically valid sample. Identification of Whether the Audit Finding was a Repeat Finding: This is not a repeat finding. Recommendation: We recommend BILH enhance its internal controls over PRF reporting to ensure each of the data elements reported to HRSA are accurate and result in amounts consistent with its underlying records. Views of Responsible Officials: Management will enhance its internal controls over PRF reporting by requiring co-sign off by the VP of System Services Accounting and the VP of Revenue/Reimbursement.
Finding 2022-02 – Reporting Program: COVID-19 Disaster Grants – Public Assistance (Presidentially Declared Disasters) Federal Agency: U.S. Department of Homeland Security Assistance Listing Number: 97.036 Criteria: Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) Subpart F – Audit Requirements §200.510 requires the auditee to prepare a schedule of expenditures of Federal awards for the period covered by the auditee’s financial statements which must include the total Federal awards expended as determined in accordance with §200.502. The Uniform Guidance requires the auditor to determine whether the auditee’s schedule of expenditures of federal awards is fairly stated, in all material respects, in relation to the audited entity’s financial statements as a whole. In addition, the Uniform Guidance places the responsibility for identifying major programs on the auditor and the schedule of expenditures of federal awards serves as the primary basis for the auditor’s major program determination. Therefore, appropriate major program determination by the auditor is dependent on the accuracy and completeness of the information in the schedule of expenditures of federal awards. Condition: In preparation of the schedule of expenditures for federal awards (SEFA) management did not record the COVID-19 Disaster Grants – Public Assistance (Presidentially Declared Disasters) expenditures on the SEFA which resulted in the SEFA being understated by $14,249,269. We deemed this to be a material weakness in internal controls. Cause: BILH did not have an adequately designed internal control to identify the error in federal awards expended as such, the amount of the errors could have been greater and not detected by BILH’s control environment. Possible Asserted Effect: Potential misstatement to the schedule of expenditures of federal awards. Questioned Costs: None noted Statistical Sampling: The sample was not intended to be, and was not, a statistically valid sample. Identification of Whether the Audit Finding was a Repeat Finding: This is not a repeat finding. Recommendation: We recommend that BILH implement a more thorough and detailed process for preparing and reviewing the SEFA to identify adjustments that could result in a misstatement of the SEFA. This should include a formalized and detailed review of the SEFA and a reconciliation to the general ledger and financial statements by someone other than the preparer. Views of Responsible Officials: Management will enhance its review process by requiring a formal second sign-off of the SEFA with supporting documents.